PMID: 11337084May 5, 2001Paper

The role of CRH in behavioral responses to stress

Peptides
G N SmaginA J Dunn

Abstract

Corticotropin-releasing hormone (CRH) and urocortin in the central nervous system affect behavior and can enhance behavioral responses to stressors. The action of CRH-related peptides is mediated through multiple receptors that differ markedly in their pharmacological profiles and anatomical distribution. Comparative pharmacology of CRH receptor agonists suggests that CRH, urocortin, sauvagine and urotensin consistently mimic, and CRH receptor antagonists consistently lessen, functional consequences of stressor exposure. Recently, important advances have been made in understanding the CRH system and its role in behavioral responses to stress by the development of specific CRH receptor antagonists, application of antisense oligonucleotides and development of transgenic mice lacking peptides and functional receptors. This review summarizes recent findings with respect to components of the CRH system and their role in stress-induced behavioral responses.

References

Jan 1, 1990·Annals of the New York Academy of Sciences·A J Dunn, C W Berridge
Apr 1, 1987·Pharmacology, Biochemistry, and Behavior·J E Sherman, N H Kalin
Nov 1, 1984·Pharmacology, Biochemistry, and Behavior·H D Veldhuis, D De Wied
Nov 1, 1983·Pharmacology, Biochemistry, and Behavior·B A GosnellA S Levine
Jun 25, 1984·Brain Research·D R BrittonJ Rivier
Dec 1, 1982·The American Journal of Anatomy·I MerchenthalerA V Schally
Nov 7, 1995·Proceedings of the National Academy of Sciences of the United States of America·J GulyasJ Rivier
Oct 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R ChenW W Vale
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·T W LovenbergT Oltersdorf
Nov 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S C HeinrichsG F Koob
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·E PotterW Vale
Feb 1, 1993·Pharmacology, Biochemistry, and Behavior·S T Ahlers, M K Salander
Sep 1, 1996·Endocrinology·C J DonaldsonW W Vale
Sep 17, 1996·Proceedings of the National Academy of Sciences of the United States of America·D W SchulzJ Heym
Mar 26, 1997·European Journal of Pharmacology·R S MansbachY L Chen
May 1, 1997·Proceedings of the Society for Experimental Biology and Medicine·A V Turnbull, C Rivier
May 6, 1997·Neuroreport·J L MoreauF Jenck
Jan 7, 1998·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·M DavisY Lee
Dec 17, 1998·The Journal of Endocrinology·L ArboreliusC B Nemeroff

❮ Previous
Next ❯

Citations

Jul 22, 2004·Brain, Behavior, and Immunity·Davide MalagoliEnzo Ottaviani
May 26, 2005·Molecular and Cellular Neurosciences·Zhongqi LiCatherine Rivier
May 17, 2005·Physiology & Behavior·Justin E Friske, Stephen C Gammie
Dec 9, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Zul MeraliHymie Anisman
Mar 15, 2003·Neuropeptides·Oliver Stiedl, Michael Meyer
Aug 21, 2003·Progress in Neurobiology·Mark J Millan
Apr 1, 2006·Journal of Chiropractic Medicine·Peter BablisDaniel A Monti
Aug 11, 2004·Behavioral Neuroscience·Stephen C GammieJustin S Rhodes
Feb 17, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Magda Alves de MedeirosLuiz Eugênio Mello
Dec 8, 2004·Postgraduate Medical Journal·S U ShahW A Littler
Mar 3, 2007·BMC Neuroscience·Stephen C GammieSharon A Stevenson
Jun 24, 2004·Expert Opinion on Investigational Drugs·Eric P Zorrilla, George F Koob
Jan 25, 2011·Neuropeptides·Soon LeeCatherine Rivier
Dec 21, 2010·Neuropeptides·A SkórzewskaAdam Płaźnik
Jun 2, 2009·Journal of Chemical Neuroanatomy·Catherine S HubbardJames D Rose
Mar 18, 2008·European Journal of Pharmacology·Joel P GallagherPatricia Shinnick-Gallagher
Oct 1, 2004·The Journal of Comparative Neurology·Mariarosa G SpinaMario Engelmann
Feb 25, 2009·Annals of the New York Academy of Sciences·Susana SilbersteinDamián Refojo
Mar 6, 2010·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Maria Kovacs, Nestor Lopez-Duran
Mar 18, 2005·Comptes rendus biologies·Jan M Deussing, Wolfgang Wurst
Oct 27, 2004·Physiology & Behavior·Janeen L Salak-JohnsonJohn J McGlone
Feb 9, 2011·Brain Research·William R LariviereAnna Maria Aloisi
Apr 20, 2006·Behavioural Brain Research·Stephen C Gammie, Sharon A Stevenson
Jan 24, 2006·General and Comparative Endocrinology·Christopher A Lowry, Frank L Moore
Dec 20, 2007·Human Psychopharmacology·Annemarie HeberleinThomas Hillemacher
Jun 13, 2015·Physiology & Behavior·Bruce S McEwenRandall R Sakai
Sep 7, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·Gabriele GhisleniCarla D Bonan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.